DataPile investor atlas

Angel investors & venture capitalists in New Jersey, United States

Last updated 27-10-2025. Data refreshed weekly.

2 Matches for your filters
27 Total investors in region
3,050 Profiles tracked nationwide
27 Based in New Jersey
Princeton (3) Largest investor hub
Princeton Equity Group, HAF Notable firms

Refine investor results

Toggle multiple filters to narrow the directory instantly.

Location

States & regions

Cities

Industry focus

We found 2 investors focused on pharmaceuticals.

Market intelligence

  • Most active investment themes in New Jersey, United States: venture capital & private equity, mechanical or industrial engineering, information technology & services.
  • 3 profiles are headquartered in Princeton, making it the busiest hub in New Jersey, United States.
  • Featured firms include Princeton Equity Group, HAF, Compucom, Keller Williams Realty, LLC.

Explore states in United States

Showing 1 – 2 of 2 investors

Renee McKnight profile photo Organon logo
Renee McKnight
Senior Investor Relations Specialist
Organon
Focus areas
pharmaceuticals pharmaceutical biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing women's health reproductive health fertility contraception maternal health vaginal health hormone replacement therapy menopause biosimilars established brands cardiovascular disease respiratory conditions dermatology central nervous system disorders bone health immunology non-opioid pain management healthcare solutions global reach accessibility innovation ethical values customer engagement diverse portfolio healthcare providers patient care women's health solutions health outcomes impactful medicines healthcare economies empowerment inclusivity collaboration accountability authenticity global healthcare company chronic disease management fertility treatments contraceptive solutions hormonal therapies heart health neurological conditions autoimmune therapies respiratory treatments vaginal health products menopause management dermatology solutions central nervous system treatments oncology products bone health treatments immunology medications patient support programs clinical trials healthcare access medical innovations participatory research patient assistance programs disease awareness health education diversity in medicine gender equity in healthcare corporate social responsibility supply chain sustainability medical compliance ethical business practices healthcare equity patient advocacy access to medications affordable healthcare global health initiatives clinical development market access strategies therapeutic areas healthcare partnerships environmental sustainability community health programs transparency in healthcare regulatory affairs stakeholder engagement financial assistance programs b2b medical health wellness & fitness pharmaceuticals hospital & health care
Location
Clifton, New Jersey, United States
Signals
Suketu Desai profile photo Bristol Myers Squibb logo
Suketu Desai
Director - Investor Relations
Bristol Myers Squibb
Focus areas
pharmaceuticals biotechnology innovation great place to work pharmaceuticals research & development healthcare health & wellness life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech r&d patient-centered b2b biotech research advances acute coronary syndrome pharmaceutical innovation clinical research biotech in inflammatory diseases atrial fibrillation blockbuster drugs immunology government biotech research platforms pharmaceutical and medicine manufacturing biotech innovation hubs cardiovascular blood clotting market leadership biotech in cancer patient resources drug discovery market access research and development healthcare providers oncology biotech manufacturing oncology drugs fibrosis treatments biotech innovation platforms therapeutics secondary stroke prevention fibrosis biotech innovation partnerships risk management biologics biotech clinical development cancer immunotherapy biotech research investments global reach financial reporting biotech partnerships biotech pipeline biopharma biotech research programs biopharmaceutical biotech innovation ecosystem biotech innovation research facilities biotech collaborations biotech in genetic disorders biotech innovation strategies cancer immunotherapy drugs oncology pipeline precision medicine immune system biotech in cardiovascular drug development biotech in neuroscience services innovative medicines biotech research centers biologics manufacturing biotech research initiatives pipeline biotech in metabolic diseases immunology pipeline biotech phase 3 clinical trials biotech in fibrosis biotech in rare diseases global healthcare clinical trials marketed drugs biotech in autoimmune diseases milvexian biotech research collaborations immunotherapy biotech research projects biotech research pipelines biotech research funding targeted therapies cancer therapy medical research neuroscience portfolio biotech research breakthroughs biotech pipeline management blood clotting disorders blood thinners cell therapy car t cell therapy cancer treatment translational medicine health equity licensed agreements generic drugs drug pricing scientific research clinical trial access disease research patient-centered care global health therapeutic areas research pipeline investors corporate responsibility disease state resources global partnerships medical information pediatric implications chronic diseases emergency protocols post-study access prescription assistance stem education community impact environmental sustainability inclusion and diversity corporate governance transparency initiatives shareholder services analyst coverage stakeholder engagement manufacturing distribution medical health wellness & fitness hospital & health care mechanical or industrial engineering
Location
Princeton, New Jersey, United States
Signals

Explore other regions in United States